David L Rimm, MD, PhD

Professor of Pathology; Director of Medical Studies; Director of Pathology Tissue Services

---

Departments & Organizations

Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development: Cytoskeleton and Cell Morphogenesis | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Cancer Center, Yale: Signal Transduction

Pathology: Cytology Service | Anatomic Pathology

---

Biography

Dr. David Rimm, is a Professor in the Department of Pathology at the Yale University School of Medicine.  He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and a Cytopathology Fellowship at the Medical College of Virginia.  He is board certified in Anatomic Pathology and Cytopathology. At Yale since 1994, Dr. Rimm is the Director of Yale Pathology Tissue Services and the Yale Tissue Microarray Facility.  He is also the Director of Medical Studies for Pathology.  His lab group (15 researchers) focuses on quantitative pathology using the AQUA® technology invented in his lab with projects related to predicting response to therapy in breast cancer and predicting recurrence or metastasis in melanoma and lung cancer.  He also has a group working on c-Met tyrosine kinase and group working on spectral/spatial imaging for diagnostics in cytology.  He is currently supported by 9 grants from both public and private sources.  He serves as a reviewer for the NIH and was a charter member of the Cancer Biomarkers Study Section.  He is an editorial board member for 7 pathology journals and a member of the pathology committee for CALGB, TransALLTO and TEACH (cooperative groups or therapeutic clinical trials). He is an author of over 180 peer-reviewed papers and 6 patents and is the scientific co-founder of HistoRx, a digital pathology company and Metamark Genetics, a prognostic determinant company.